BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 28502014)

  • 1. Inventions and Patents: A Practical Tutorial.
    Mehta H; Tidwell L; Liotta LA
    Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inventions and patents: a practical tutorial.
    Tidwell JL; Liotta LA
    Methods Mol Biol; 2012; 823():391-408. PubMed ID: 22081360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patents: a tool to bring innovation from the lab bench to the marketplace.
    Li ZY; Meyer W
    Methods Mol Biol; 2014; 1152():297-310. PubMed ID: 24744041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
    Mull WC
    Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patenting inventions in the field of biology and chemistry: German and European patent law and case law.
    Vossius V
    Naturwissenschaften; 1997 Oct; 84(10):431-43. PubMed ID: 9394296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Must an inventor "possess" an invention to patent it?
    Woessner WD; Chadwick RA
    Cold Spring Harb Perspect Med; 2014 Sep; 4(11):a020867. PubMed ID: 25237144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the Bench to the Pharmacy: Protecting Innovation During Vaccine Development and Commercialization.
    Krol AC; Abu-Shaar M; Brady P
    Methods Mol Biol; 2016; 1404():813-834. PubMed ID: 27076339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to Intellectual Property: A U.S. Perspective.
    Murphy A; Stramiello M; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Mar; 5(8):a020776. PubMed ID: 25818665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation.
    Dhulap S; Kulkarni M
    Pharm Pat Anal; 2019 Jul; 8(4):91-107. PubMed ID: 31414965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patenting DNA.
    Bobrow M; Thomas S
    Curr Opin Mol Ther; 2002 Dec; 4(6):542-7. PubMed ID: 12596355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japan's patent issues relating to life science therapeutic inventions.
    Tessensohn JA
    Expert Opin Ther Pat; 2014 Sep; 24(9):953-7. PubMed ID: 25089628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patenting and licensing in genetic testing.
    ESHG Working Party on Patenting and Licensing
    Eur J Hum Genet; 2008 Apr; 16(4):405-11. PubMed ID: 18354424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions.
    Pereira DJ; Kunin SG
    Cold Spring Harb Perspect Med; 2014 Dec; 5(4):. PubMed ID: 25475106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patenting medical inventions.
    Schwertner HA
    Mil Med; 1994 Dec; 159(12):729-32. PubMed ID: 7723995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patents and the supply of therapeutic products.
    Hayhurst WL
    Law Med Health Care; 1992; 20(3):235-7. PubMed ID: 1434767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canada's Supreme Court abolishes 'promise of the patent'.
    Norman J; Gloor A
    Pharm Pat Anal; 2018 Jan; 7(1):1-5. PubMed ID: 29227204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.